Miromatrix Medical Inc. (MIRO)
NASDAQ: MIRO
· Real-Time Price · USD
3.39
0.02 (0.59%)
At close: Dec 12, 2023, 10:00 PM
Miromatrix Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 958.03K | 959.25K | 954.68K | 953.47K | 31.11K | 28.54K | 33.73K | 33.07K | 40.27K | 41.3K | 41.55K |
Cost of Revenue | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K |
Gross Profit | 458.03K | 459.25K | 454.68K | 453.47K | -468.88K | -471.46K | -466.27K | -466.93K | -459.73K | -458.7K | -458.45K |
Operating Income | -28.48M | -29.61M | -31.15M | -30.24M | -28.64M | -26.1M | -21.43M | -16.96M | -13.85M | -11.23M | -10.52M |
Interest Income | 592.89K | 539.76K | 434.68K | 333.47K | 206.53K | 63.74K | 2.7K | 1.97K | 901.00 | 229.00 | 2.91K |
Pretax Income | -27.41M | -28.58M | -30.24M | -29.96M | -28.49M | -25.92M | -21.44M | -14.67M | -10.28M | -8.22M | -7.79M |
Net Income | -27.12M | -28.17M | -29.82M | -29.83M | -28.36M | -25.92M | -21.44M | -14.67M | -10.28M | -8.22M | -7.79M |
Selling & General & Admin | 8.99M | 8.9M | 9.05M | 8.72M | 8.32M | 7.76M | 6.35M | 4.64M | 3.42M | 2.39M | 2.21M |
Research & Development | 16.25M | 17.32M | 18.69M | 18.3M | 16.62M | 15.4M | 12.89M | 10.75M | 9.23M | 7.75M | 7.35M |
Other Expenses | 7.88M | 5.88M | 2.93M | 1.94M | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 28.94M | 30.06M | 31.61M | 30.7M | 28.17M | 25.51M | 20.72M | 16.1M | 12.8M | 9.96M | 9.1M |
Interest Expense | 46.41K | 46.45K | 47.08K | 47.73K | 47.6K | 47.53K | 349.45K | 676.52K | 989.62K | 1.22M | 1.06M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.44M | 30.56M | 32.11M | 31.2M | 28.67M | 26.01M | 21.22M | 16.6M | 13.3M | 10.46M | 9.6M |
Income Tax Expense | -289.74K | -417.97K | -356.89K | -56.07K | -56.26K | 87.22K | 26.15K | 15.26K | 15.26K | n/a | n/a |
Shares Outstanding (Basic) | 27.31M | 27.25M | 22.51M | 20.91M | 20.9M | 20.62M | 20.48M | 20.33M | 20.15M | 18.96M | 17.77M |
Shares Outstanding (Diluted) | 27.31M | 27.25M | 22.51M | 20.91M | 20.9M | 20.62M | 20.48M | 20.39M | 20.15M | 18.96M | 17.77M |
EPS (Basic) | -1.13 | -1.25 | -1.41 | -1.44 | -1.38 | -1.27 | -1.07 | -0.74 | -0.57 | -0.6 | -0.71 |
EPS (Diluted) | -1.13 | -1.25 | -1.41 | -1.44 | -1.38 | -1.27 | -1.07 | -0.74 | -0.57 | -0.6 | -0.71 |
EBITDA | -26.79M | -27.97M | -29.63M | -29.09M | -27.62M | -25.35M | -20.86M | -16.69M | -14.04M | -11.7M | -11.37M |
EBIT | -27.48M | -28.66M | -30.31M | -30.03M | -28.44M | -25.87M | -21.09M | -13.99M | -9.29M | -7M | -6.73M |
Depreciation & Amortization | 1.33M | 1.47M | 1.52M | 1.15M | 1.1M | 707.09K | 401.55K | 167.91K | 124.02K | 124.52K | 132.46K |